Identification of novel ER-α target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17β-estradiol and tamoxifen

Andrea Romano , Michiel Adriaens , Sabine Kuenen , Bert Delvoux , Gerard Dunselman , Chris Evelo , Patrick Groothuis

Tamoxifen and 17β-estradiol are capable of up-regulating the expression of some genes and down-regulate the expression of others simultaneously in the same cell. In addition, tamoxifen shows distinct transcriptional activities in different target tissues.To elucidate whether these events are determined by differences in the recruitment of co-regulators by activated estrogen receptor-α (ER-α) at target promoters, we applied chromatin-immunoprecipitation (ChIP) with promoter microarray hybridisation in breast cancer T47D cells and identified 904 ER-α targets genome-wide. On a selection of newly identified targets, we show that 17β-estradiol and tamoxifen stimulated up- or down-regulation of transcription correlates with the selective recruitment of co-activators or co-repressors, respectively. This is shown for both breast (T47D) and endometrial carcinoma cells (ECC1). Moreover, differential co-regulator recruitment also explains that tamoxifen regulates a number of genes in opposite direction in breast and endometrial cancer cells. Over-expression of co-activator SRC-1 or co-repressor SMRT is sufficient to alter the transcriptional action of tamoxifen on a number of targets. Our findings support the notion that recruitment of co-regulator at target gene promoters and their expression levels determine the effect of ER-α on gene expression to a large extent.

Mots clés: 17β-estradiol; estrogen receptor-α; co-activators; Co-repressors; tamoxifen

Andrea Romano, Michiel Adriaens, Sabine Kuenen, Bert Delvoux, Gerard Dunselman, et al.. Identification of novel ER-α target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17β-estradiol and tamoxifen. Molecular and Cellular Endocrinology, 2009, 314 (1), pp.90. ⟨10.1016/j.mce.2009.08.008⟩. ⟨hal-00529008⟩